Corneal Endothelial Cell Culture

Schepens Eye Research Institute
posted on 03/04/2009

Human endothelial cells are different from vascular and pulmonary endothelial cells as they have a different tissue origin. Human corneal endothelial cells do not normally proliferate in vivo to replace those lost due to cell injury or death and the growth of these cells in culture is also extremely limited. The new growth method uses an agent that interrupts cell-to-cell contact. In addition, the medium contains growth factors that promote the proliferation of corneal endothelial cells. The new formulation permits the consistent growth of older donor cells which was previously particularly difficult to achieve. The new medium formulation would have a great impact in the field of corneal transplantation to increase the endothelial cell density of donor corneas or to produce artificial corneal constructs. The new formulation can also be used for research purposes, to induce proliferation of ocular cells and non-ocular cells such as sensory neurons.

Innovation Details

File Number: SERI-115 

Other Information:

Ph.D. Nancy Joyce

Mary Chatterton, Director of Corporate Alliances.

IP Protection

License Online

This innovation currently is not available for online licensing. Please contact the case manager at Schepens Eye Research Institute for more information.

Request more info via email request more info

No people are currently associated with this innovation.

Download Technology Brief (PDF)

Followed By

Follow this innovation

No one is following this innovation.

Related Tags

Find more innovations

February 11, 2009

13,559 members 17,721 innovations 176 organizations


Scott Steele, coordinator of the CTSA-IP initiative and director of research alliances at the University of Rochester

"With more than 3,700 innovations from CTSA member institutions already on the iBridge Network, we're garnering worldwide exposure for the breakthroughs our researchers are accomplishing while moving toward our goal of increasing human health through clinical and translational research."  read more...